Korro Bio is trading at $14.69, up 6.37%, with no clear catalyst identified.

  • No new company-specific announcement was identified for September 14, 2026.
  • The latest disclosed item was a September 11 inducement grant under Nasdaq rules, but available coverage does not explicitly connect it to today’s gain.
  • Broader markets are lower, so overall market strength does not explain the move.